Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Jess Dyson.

Newcastle AuthorsTitleYearFull text
Dr David Adams
Dr Jess Dyson
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis2022
Abdullah Malik
Sanjay Pandanaboyana
Gourab Sen
Dr Stuart McPherson
Dr Jess Dyson
et al.
Risk factors for decompensation and death following umbilical hernia repair in patients with end-stage liver disease2022
Dr Jess Dyson
Professor David Jones
Bezafibrate for the Treatment of Cholestatic Pruritus: Time for a Change in Management?2021
Dr Laura Neilson
Dr Louise MacDougall
Dr Timothy Hardy
Dr David Beaton
Dr April Phaw
et al.
Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease2021
Dr April Phaw
Dr Jess Leighton
Dr Jess Dyson
Professor David Jones
Managing cognitive symptoms and fatigue in cholestatic liver disease2021
Dr Jess Leighton
Dr Jess Dyson
Professor David Jones
Patient ownership of primary biliary cholangitis long-Term management2021
Dr Aaron Wetten
Professor David Jones
Dr Jess Dyson
Specific considerations for the management of primary biliary cholangitis: are the drug treatment options good enough?2021
Dr Ben Barron-Millar
Dr Laura Ogle
Professor John Kirby
Dr Jeremy Palmer
Dr Laura Jopson
et al.
The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis2021
Dr April Phaw
Dr Jess Dyson
Professor David Jones
Understanding Fatigue in Primary Biliary Cholangitis2021
Dr April Phaw
Dr Jess Dyson
Professor David Jones
Emerging drugs for the treatment of primary biliary cholangitis2020
Dr Jess Dyson
Steven White
Pregnancy outcomes in women with liver transplants: systematic review and meta-analysis2020
Dr Jess Dyson
Review article: experimental therapies in autoimmune hepatitis2020
Dr Jess Dyson
Professor David Jones
UDCA prophylaxis for post-transplant PBC recurrence prevention: Time to change practice2020
Dr Jess Dyson
Professor David Jones
British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis2019
Dr Jess Dyson
Dr Mark Hudson
Paediatric to adult liver transition services: the state of play in the UK2019
Dr Jess Dyson
Dr Mark Hudson
Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: Fourth report of the Lancet Standing Commission on Liver Disease in the UK2018
Dr Jess Dyson
Dr Lin Lee Wong
Dr Theophile Bigirumurame
Dr Stuart Kendrick
Professor David Jones
et al.
Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom2018
Dr Jess Dyson
Professor David Jones
Dr Mark Hudson
Primary sclerosing cholangitis2018
Dr Jess Dyson
Dr Dina Tiniakos
Professor David Jones
The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines2018
Dr Lin Lee Wong
Dr Holly Fisher
Dr Deborah Stocken
Stephen Rice
Dr Amardeep Khanna
et al.
The Impact of Autoimmune Hepatitis and Its Treatment on Health Utility2018
Dr Jess Dyson
Adult parenteral nutrition in the North of England: A region-wide audit2017
Dr Stuart McPherson
Dr Jess Dyson
Dr Mark Hudson
Editorial: improving in-hospital management of decompensated cirrhosis by a ‘care bundle’ – hope, frustration and lessons to learn. Authors’ reply2017
Dr Jess Dyson
Dr Mark Hudson
New metrics for the Lancet Standing Commission on Liver Disease in the UK2017
Dr Gary Reynolds
Dr Lin Lee Wong
Professor David Jones
Dr Jess Dyson
Balance between exhausted regulatory T cells and CD161(+) NK cells is crucial in acute AIH pathogenesis2016
Kile Green
Dr Laura Jopson
Dr Ben Barron-Millar
Barbara Innes
Sarah Pagan
et al.
Early Molecular Stratification of High-risk Primary Biliary Cholangitis2016
Dr Jess Dyson
Professor David Jones
Early Primary Biliary Cholangitis is Characterised by Brain Abnormalities on Cerebral Magnetic Resonance Imaging2016
Dr Jess Dyson
Dr Chris Lamb
Dr Steven Masson
Dr Mark Hudson
Dr Christian Dipper
et al.
Implementation of a “care bundle” improves the management of patients admitted to hospital with decompensated cirrhosis2016
Dr Jess Dyson
Dr Laura Jopson
Dr Sheila Waugh
Dr Stuart McPherson
Improving testing for hepatitis B before treatment with rituximab2016
Dr Jess Dyson
Dr Dina Tiniakos
Dr Stuart McPherson
Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use2016
Dr Vinod Hegade
Dr Amardeep Khanna
Dr Lucy Walker
Dr Lin Lee Wong
Dr Jess Dyson
et al.
Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score2016
Dr Jess Dyson
Dr Stuart McPherson
Reply to "Liver Failure in Human Immunodeficiency Virus - Hepatitis C Virus Coinfection Treated with Sofosbuvir, Ledipasvir and Antiretroviral Therapy"2016
Dr Stuart McPherson
Dr Jess Dyson
Dr Mark Hudson
Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h2016
Dr Jess Dyson
Dr Nina Wilson
Dr Laura Jopson
Samantha Ducker
Dr Deborah Stocken
et al.
The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis2016
Dr Lin Lee Wong
Dr Stuart Kendrick
Professor David Jones
Dr Jess Dyson
UK-AIH - Highlighting the need for standardization of treatment in autoimmune hepatitis2016
Dr Laura Jopson
Dr Jess Dyson
Professor David Jones
Understanding and Treating Fatigue in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis2016
Dr Jess Dyson
Dr Jeremy Palmer
Dr Lin Lee Wong
Dr Stuart Kendrick
Professor David Jones
et al.
Understanding the importance of pro- and anti-inflammatory cytokines in autoimmune hepatitis2016
Dr Lin Lee Wong
Dr Stuart Kendrick
Dr Jess Dyson
Professor David Jones
Understanding the unmet need in Autoimmune Hepatitis - The United Kingdom AIH Study (UK-AIH)2016
Dr Jess Dyson
Dr Steven Masson
Dr Stuart McPherson
Professor Derek Manas
Dr Mark Hudson
et al.
Experience of Using Advagraf in a Single Liver Transplant Centre in the United Kingdom2015
Dr Jess Dyson
Dr Ahmed Elsharkawy
Dr Chris Lamb
Dr Ahmad Al-Rifai
Professor Julia Newton
et al.
Fatigue in primary sclerosing cholangitis is associated with sympathetic over-activity and increased cardiac output2015
Kile Green
Sarah Pagan
Dr Jess Dyson
Dr Lucy Walker
Dr Laura Jopson
et al.
High-risk primary biliary cirrhosis has a distinct molecular signature opening the way for a molecular approach to stratified therapeutics2015
Dr Jess Dyson
Dr Steven Masson
Dr Stuart McPherson
Dr Mark Hudson
Impact of a Nurse-Led Annual Review Clinic for Liver Transplant Recipients2015
Dr Jess Dyson
Dr Chris Lamb
Dr Mark Hudson
Dr Stuart McPherson
Implementation and impact of a care bundle for the management of patients with decompensated liver disease2015
Dr Jess Dyson
Dr Mark Hudson
Implementation of the Lancet Standing Commission on Liver Disease in the UK2015
Dr Jess Dyson
Dr Stuart McPherson
Dr Steven Masson
Dr Mark Hudson
Importance of Health Education in an Annual Review Liver Transplant Clinic in the United Kingdom2015
Dr Jess Dyson
Professor Quentin Anstee
Dr Stuart McPherson
Non-alcoholic fatty liver disease: a practical approach to treatment2015
Dr Jess Dyson
Professor Derek Mann
Professor David Jones
Novel therapeutic targets in primary biliary cirrhosis2015
Dr Jess Dyson
Dr Laura Jopson
Dr Stuart McPherson
Rituximab and hepatitis B: are we doing it right?2015
Dr Jess Dyson
Professor David Jones
Unmet clinical need in autoimmune liver diseases2015
Dr Jess Dyson
Dr Mark Hudson
Professor Derek Manas
Dr Steven Masson
A Positive Complement Dependent Cytotoxic (CDC) Crossmatch Does Not Impact on Patient Survival or Increase the Risk of Acute Cellular Rejection, or Biliary Strictures after Liver Transplantation2014
Dr Jess Dyson
Dr Laura Jopson
Samantha Ducker
Professor David Jones
Age at Presentation and Gender are Predictors of Increased Mortality Over Long-Term Follow-Up in Primary Biliary Cirrhosis (PBC)2014
Dr Jess Dyson
Professor David Jones
Diagnosis and Management of Patients with primary biliary cirrchosis2014
Dr Jess Dyson
Dr Dipanker Chattopadhyay
Rajiv Lochan Jayadeva
Dr Imran Patanwala
Mike Cole
et al.
Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team2014
Dr Jess Dyson
Dr Mark Hudson
Dr Stuart McPherson
Lesson of the month 2: Severe reactivation of hepatitis B after immunosuppressive chemotherapy2014
Dr Jess Dyson
Dr Stuart McPherson
Professor Quentin Anstee
Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification2014
Dr Jess Dyson
Professor James Mason
Dr Matthew Rutter
Prior hysterectomy and discomfort during colonoscopy: a retrospective cohort analysis2014
Dr Jess Dyson
Dr Laura Jopson
Samantha Ducker
Professor David Jones
The Impact of Age at Presentation on Symptoms in Primary Biliary Cirrhosis2014
Dr Laura Jopson
Dr Jess Dyson
Professor David Jones
The New Epidemiology of Primary Biliary Cirrhosis2014
Dr Jess Dyson
Professor Chris Day
Treatment of Non-Alcoholic Fatty Liver Disease2014
Dr Jeremy Palmer
Professor David Jones
Dr Jess Dyson
Professor John Kirby
Understanding the Mechanisms Underpinning Treatment Non-Response in Primary Biliary Cirrhosis: A Tool for Treatment Stratification2014
Dr Jeremy Palmer
Dr Jess Dyson
Professor David Jones
Professor John Kirby
Understanding the mechanisms underpinning treatment non-response in Primary Biliary Cirrhosis: a tool for treatment stratification2014
Dr Laura Jopson
Professor David Jones
Dr Jess Dyson
Younger patients presenting with Primary Biliary Cirrhosis are more likely to have cognitive impairment2014
Dr Jess Dyson
Dr Stuart McPherson
Professor Quentin Anstee
Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification2013